Adalimumab rapidly controls both anterior and posterior inflammation in patients with ocular Behçet syndrome and non-infectious uveitis refractory to conventional …

C Evereklioglu, HK Sonmez, DG Sevim, H Arda… - International …, 2023 - Springer
Purpose To evaluate the efficacy and safety of adalimumab (ADA, Humira®) for treatment of
non-infectious uveitis (NIU) refractory to conventional medications. Methods Anti-tumor …
被引用次数：2 相关文章

Adalimumab rapidly controls both anterior and posterior inflammation in patients with ocular Behçet syndrome and non-infectious uveitis refractory to conventional …

C Evereklioglu, HK Sonmez, DG Sevim… - International …, 2023 - europepmc.org
Purpose To evaluate the efficacy and safety of adalimumab (ADA, Humira®) for treatment of
non-infectious uveitis (NIU) refractory to conventional medications. Methods Anti-tumor …

Adalimumab rapidly controls both anterior and posterior inflammation in patients with ocular Behcet syndrome and non-infectious uveitis refractory to conventional …

CEM EVEREKLİOĞLU, H SÖNMEZ… - INTERNATIONAL …, 2023 - avesis.erciyes.edu.tr
PurposeTo evaluate the efficacy and safety of adalimumab (ADA, Humira (& REG;)) for
treatment of non-infectious uveitis (NIU) refractory to conventional medications. MethodsAnti …

Adalimumab rapidly controls both anterior and posterior inflammation in patients with ocular Behçet syndrome and non-infectious uveitis refractory to conventional …

C Evereklioglu, HK Sonmez… - International …, 2023 - pubmed.ncbi.nlm.nih.gov
Purpose To evaluate the efficacy and safety of adalimumab (ADA, Humira®) for treatment of
non-infectious uveitis (NIU) refractory to conventional medications. Methods Anti-tumor …